VAMTAJ is the single-family office of an innovative French entrepreneur. Biotech investment is a key focus of our Private Equity strategy. We invest in funds and direct participation.

Baerenkraft Therapeutics is redefining the conventional drug development model by deploying a flexible, capital-efficient, and partner-centric strategy designed for the realities of today’s global the ...

Oryn is a clinical-stage biotech company developing a new class of macrocyclic peptides to restore the immune balance.

We are a commercial stage biopharmaceutical company focused on the development and commercialization of next generation, clinically superior versions of recombinant therapeutic proteins through our Pr ...

Streamlined, efficient, pulse of venture debt financing.

Feldan is developing treatments based on the intracellular delivery of compounds known to be safe and highly specific toward their targets. These can be proteins, peptides, small molecules and antisen ...

iTolerance is an early stage privately held regenerative medicine company developing technology to enable tissue, organoid or cell therapy without the need for life-long immunosuppression.

Portfolio manager, investor, and wealth advisor with a niche in young biotech and healthcare companies. Tax efficient financial and operational strategies for businesses, executives, and families.

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible. The company is also developing innovative interventions to address debilitating c ...